NanoDoce

NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer
Pharmaceutical Business Review
Wed, 04/10/19 - 09:42 am
NanOlogy
bladder cancer
NanoDoce
clinical trials